LOTUS PHARMACEUTICAL CO earnings per share and revenue

1795 earnings per share for the last quarter are 4.33 TWD whereas the estimation was 3.34 TWD which accounts for 29.70% surprise. Company revenue for the same period amounts to 4.41 B TWD despite the estimated figure of 4.31 B TWD. Estimated earnings per share for the next quarter are 3.61 TWD, and revenue is expected to reach 4.35 B TWD. Also watch annual changes over time to get a bigger picture of 1795 earnings per share and revenue dynamics.